PSMD4 and malignant colon neoplasm: Knocking out PSMD4 in MC38 colon cancer cells had no effect on cell proliferation but significantly weakened the immunotherapeutic effect of atractylenolide-I (ATT-I), which suggested that PSMD4 should play an important role in immunotherapy [36].